Proton Pump Inhibitors and the Risk of Adverse Cardiac Events

Proton-Pump Inhibitors Are Associated With Increased Cardiovascular Risk Independent of Clopidogrel Use

(2013) Mette Charlot   ANNALS OF INTERNAL MEDICINE

Association of Proton Pump Inhibitor Use on Cardiovascular Outcomes With Clopidogrel and Ticagrelor

(2012) Shaun G. Goodman et al.   CIRCULATION

A systematic review of validated methods for identifying heart failure using administrative data

(2012) Jane S. Saczynski et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The risk of hypotension following co-prescription of macrolide antibiotics and calcium-channel blockers

(2011) A. J. Wright et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Trimethoprim-Sulfamethoxazole–Induced Hyperkalemia in Patients Receiving Inhibitors of the Renin-Angiotensin System

(2010) Tony Antoniou   ARCHIVES OF INTERNAL MEDICINE

Differential Effects of Omeprazole and Pantoprazole on the Pharmacodynamics and Pharmacokinetics of Clopidogrel in Healthy Subjects: Randomized, Placebo-Controlled, Crossover Comparison Studies

(2010) D J Angiolillo et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Recent in vitro findings of negative inotropy of pantoprazole did not translate into clinically relevant effects on left ventricular function in healthy volunteers

(2009) Wolfgang Schillinger et al.   Clinical Research in Cardiology

Safety of influenza vaccination in patients with myasthenia gravis: A population-based study

(2009) Lorne Zinman et al.   MUSCLE & NERVE

Inappropriate prescription of proton pump inhibitors on two pulmonary medicine wards

(2008) Evelyn P.M. van Vliet et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY